ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,692, issued on April 8.
"Combinatorial targeted therapy methods" was invented by Soonkap Hahn (Irvine, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A combinatorial targeted therapy method for treating cancer, including metastatic cancer in a subject is provided, the method being designed to prevent unacceptable level of systemic toxicity in the subject and thus forced stoppage of the treatment, by performing initial molecular diagnostics to detect genomic alterations at each cancer site of the subject; for each cancer site, designing an initial combination targeted therapy by selecting a plurality of targeted drugs, based on the results of ...